Development and use of sulodexide in vascular diseases: implications for treatment.
about
Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddasesSulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature reviewSulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life.Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.The blood pressure lowering potential of sulodexide--a systematic review and meta-analysisOmics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine.Endothelial glycocalyx-the battleground for complications of sepsis and kidney injury.Therapeutic Restoration of Endothelial Glycocalyx in Sepsis.Italian survey on benign paroxysmal positional vertigo.Pharmacological adjuncts for chronic venous ulcer healing.Chronic Venous Insufficiency: Transforming Growth Factor-β Isoforms and Soluble Endoglin Concentration in Different States of Wound Healing.Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model.A Fluorescent Probe for Glycosaminoglycans Applied to the Detection of Dermatan Sulfate by a Mix-and-Read Assay.Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.Chronic Venous Disorders: The Dangerous, the Good, and the DiverseSulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
P2860
Q26828872-89DE613F-8F11-43D2-8F75-E9F9B60364D6Q28083781-F5105CD4-763D-4390-B4ED-94939AE03E0DQ30489548-A41165F8-EA79-4B79-8C7E-A696D9BF9559Q36276886-9F125240-C425-4F2C-ACFD-78430272EE25Q36410118-9E17D5EA-37EA-49ED-9BE4-D8D2D77E3F79Q38219420-84D3C804-9EEE-4ADB-B688-D6F5BC37E4BBQ38768931-8B6384E2-CE11-4C67-BB48-DE44D3387D18Q40342607-AC810549-5B36-4873-A965-99836077D815Q41611773-EF47A8BF-54CC-4B6E-8BB6-1E99623D60A4Q42779887-6AC34AAA-C2E1-4B62-A739-5E834DEFD8A3Q47136193-9DC763EA-A617-443E-9F8C-F9098A1C17AEQ47327736-F394AE30-F755-4A7F-9467-D4A7C12C3347Q50207858-E6475696-05CE-48EF-AF93-FA9E62066FD3Q55647358-907219D6-3E26-45A2-A4B8-E81D9BB767F4Q58697259-3DA98185-1034-48FA-AFDF-7929A8F8E784Q58795422-C3918720-D249-4340-B99F-42AAAEF5C1A3
P2860
Development and use of sulodexide in vascular diseases: implications for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development and use of sulodexide in vascular diseases: implications for treatment.
@en
Development and use of sulodexide in vascular diseases: implications for treatment.
@nl
type
label
Development and use of sulodexide in vascular diseases: implications for treatment.
@en
Development and use of sulodexide in vascular diseases: implications for treatment.
@nl
prefLabel
Development and use of sulodexide in vascular diseases: implications for treatment.
@en
Development and use of sulodexide in vascular diseases: implications for treatment.
@nl
P2860
P356
P1476
Development and use of sulodexide in vascular diseases: implications for treatment.
@en
P2093
Ferdinando Mannello
Sergio Coccheri
P2860
P356
10.2147/DDDT.S6762
P407
P5008
P577
2013-12-24T00:00:00Z